MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
407.56%
Quick Ratio
407.56%
Cash Ratio
393.88%
Debt to Asset Ratio
24.54%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating leases right-of-use as...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
36,473
42,132
47,998
53,391
Prepaid expenses and other current assets
1,267
1,129
1,383
975
Total current assets
37,740
43,261
49,381
54,366
Property and equipment, net of accumulated depreciation of 846 and 1,064
700
268
295
226
Restricted cash long-term
339
337
335
332
Operating leases right-of-use assets, net
1,373
1,565
1,754
1,215
Finance leases right-of-use assets, net
5
7
10
12
Total assets
40,157
45,438
51,775
56,151
Accounts payable and accrued expenses
8,514
6,615
7,247
6,224
Operating leases current liability
741
726
711
599
Finance leases current liability
5
8
11
11
Total current liabilities
9,260
7,349
7,969
6,834
Long-term license revenue deferred
-
35,000
35,000
35,000
Long-term operating lease obligations
595
785
972
531
Long-term finance lease obligations
-
-
-
2
Total liabilities
9,855
43,134
43,941
42,367
Common stock, 0.001 par value 1,000,000,000 shares authorized 31,374,991 and 31,195,891 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
31
31
31
31
Additional paid-in capital
417,665
417,547
417,536
417,526
Accumulated other comprehensive loss
-60
-39
-20
-
Accumulated deficit
-387,334
-415,235
-409,713
-403,773
Total stockholders equity
30,302
2,304
7,834
13,784
Total liabilities and stockholders equity
40,157
45,438
51,775
56,151
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$36,473K (-39.14%↓ Y/Y)Prepaid expenses andother current assets$1,267K (15.08%↑ Y/Y)Total current assets$37,740K (-38.16%↓ Y/Y)Operating leasesright-of-use assets, net$1,373K (0.00%↑ Y/Y)Property and equipment,net of accumulated...$700K (158.30%↑ Y/Y)Restricted cash long-term$339K (3.04%↑ Y/Y)Finance leasesright-of-use assets, net$5K (-66.67%↓ Y/Y)Total assets$40,157K (-36.28%↓ Y/Y)Total liabilities andstockholders equity$40,157K (-36.28%↓ Y/Y)Total stockholdersequity$30,302K (59.38%↑ Y/Y)Total liabilities$9,855K (-77.60%↓ Y/Y)Accumulated deficit-$387,334K (2.84%↑ Y/Y)Accumulated othercomprehensive loss-$60K Additional paid-in capital$417,665K (0.01%↑ Y/Y)Total currentliabilities$9,260K (11.38%↑ Y/Y)Long-term operating leaseobligations$595K (-13.14%↓ Y/Y)Common stock, 0.001 parvalue 1,000,000,000...$31K (0.00%↑ Y/Y)Accounts payable andaccrued expenses$8,514K (10.37%↑ Y/Y)Operating leases currentliability$741K (25.81%↑ Y/Y)Finance leases currentliability$5K (-54.55%↓ Y/Y)

Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. (ATNM)